Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.61 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.61 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.57 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 2/20 | 0.47 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.46 |
| ▸ | SMO | Q99835 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21692173 | 1.00 | ATM (0.62) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL12076750 | 0.95 | MKNK1 (0.57) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL5533122 | 0.92 | MKNK1 (0.55) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL15496379 | 0.88 | CYP2A6 (0.68) | ATMMKNK1MKNK2CYP11B1CYP11B2 | |
| SCHEMBL18745741 | 0.86 | HSD17B10 (0.65) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL18212414 | 0.86 | MKNK1 (0.59) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL12345157 | 0.86 | MKNK1 (0.50) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL28594491 | 0.86 | MKNK1 (0.50) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL12339167 | 0.86 | MKNK1 (0.55) | ATMMKNK1MKNK2CHRNA7CYP11B1 | |
| SCHEMBL5331238 | 0.84 | ATM (0.63) | ATMMKNK1MKNK2CHRNA7CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118027957-A | Method for manufacturing long afterglow photon glass by long afterglow molecular microsphere and ink-jet printing and application thereof | 中山大学 | 2024-05-14 | — | — | CN | claimed |
| CN-113979927-B | Method for preparing fluorescent molecules through intermolecular self-assembly | 常州大学 | 2023-07-25 | — | — | CN | claimed |
| CN-116284510-A | Metallocene catalyst, preparation method and application thereof | 万华化学集团股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-113979927-A | Method for preparing fluorescent molecule through intermolecular self-assembly | 常州大学 | 2022-01-28 | — | — | CN | claimed |
| WO-2026090602-A1 | PIGMENTED RESIN AND CATALYST COMPOSITIONS | MATERIA, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-3110862-B1 | ADHESION PROMOTER COMPOSITIONS FOR CYCLIC OLEFIN RESIN COMPOSITIONS | ExxonMobil Product Solutions Company (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4683900-A2 | ROMP AND THERMAL INSULATION COMPOSITIONS AND MATERIALS AND USE THEREOF | Materia, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| WO-2025245037-A1 | CYCLIC OLEFIN COMPOSITIONS, ROMP COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | MATERIA, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| EP-4194092-B1 | SYNTHESIS AND CHARACTERIZATION OF METATHESIS CATALYSTS | UMICORE AG & CO KG (DE) | 2025-10-22 | — | — | EP | disclosed |
| EP-4581071-A1 | METHOD FOR PRODUCING A MATERIAL FOR A MEMBRANE, MATERIAL, MEMBRANE AND USE OF A MEMBRANE | Forschungszentrum Jülich GmbH (DE) | 2025-07-09 | — | — | EP | disclosed |
| EP-2970522-B1 | IN-MOLD COATING OF ROMP POLYMERS | MATERIA INC (US) | 2025-05-21 | — | — | EP | disclosed |
| EP-3013886-B1 | THERMAL INSULATION | MATERIA INC (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2004013198-A2 | SYNTHESIS OF MACROCYCLIC POLYMERS BY RING INSERTION POLYMERIZATION OF CYCLIC OLEFIN MONOMERS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2004-02-12 | — | — | WO | disclosed |
| US-20030236427-A1 | Cross-metathesis of olefins directly substituted with an electron-withdrawing group using transition metal carbene catalysts | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-12-25 | — | — | US | disclosed |
| JP-2003331646-A | ION CONDUCTIVE COMPOSITION | TOKUYAMA CORP | 2003-11-21 | — | — | JP | disclosed |
| WO-2003087167-A2 | CROSS-METATHESIS OF OLEFINS DIRECTLY SUBSTITUTED WITH AN ELECTRON-WITHDRAWING GROUP USING TRANSITION METAL CARBENE CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-10-23 | — | — | WO | disclosed |
| US-5438143-A | Process for the preparation of substituted pyridines via 1-aza-1,3-butadienes and the 1-aza-1,3-butadiene intermediates | DSM N.V. (NL) | 1995-08-01 | — | — | US | disclosed |
| EP-0543880-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDINES VIA 1-AZA-1,3-BUTADIENES AND THE 1-AZA-1,3-BUTADIENE INTERMEDIATES | DSM NV (NL) | 1995-04-19 | — | — | EP | disclosed |
| EP-0543880-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDINES VIA 1-AZA-1,3-BUTADIENES AND THE 1-AZA-1,3-BUTADIENE INTERMEDIATES. | DSM NV (NL) | 1993-06-02 | — | — | EP | disclosed |
| WO-1992002505-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDINES VIA 1-AZA-1,3-BUTADIENES AND THE 1-AZA-1,3-BUTADIENE INTERMEDIATES | DSM N.V. (NL) | 1992-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236427-A1 | Cross-metathesis of olefins directly substituted with an electron-withdrawing group using transition metal carbene catalysts | OXER1, DUOX2, AOC2 | ATM 1627/4885MKNK1 2014/4885MKNK2 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.